Apremilast for Atopic Dermatitis - A Pilot Study in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Atopic Dermatitis
Interventions
DRUG

Apremilast

20mg of Apremilast taken orally BID for 3 months or 30 mg of Apremilast taken orally BID for 6 months.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Oregon Health and Science University

OTHER

NCT01393158 - Apremilast for Atopic Dermatitis - A Pilot Study in Adults | Biotech Hunter | Biotech Hunter